3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
7
Lymphoma
4
Neutropenia
3
Lymphoma, Large B-Cell, Diffuse
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Multiple Myeloma
2
Central Nervous System Neoplasms
2
Breast Neoplasms, Male
2
Triple Negative Breast Neoplasms
1
Seminoma
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Febrile Neutropenia
1
Endodermal Sinus Tumor
1
Chemotherapy-induced Neutropenia
1
Interventions
Meropenem
2
pegfilgrastim
1
Vancomycin
1
TKN732
1
Simvastatin
1
Piperacillin, Tazobactam Drug Combination
1
Magnetic Resonance Myelography
1
Levofloxacin
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Ceftazidime
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Febrile Neutropenia
×
pegfilgrastim
×
Clear all
NCT04662892
2020-12-23
POEM
Coherus Oncology, Inc.
Unknown
200 enrolled